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Previous reports showed the protective effect of the 
synthetic antioxidant butylated hydroxytoluene (BHT) 
against the chromosomal damage induced by bleomycin 
(BLM), cadmium chloride and potassium dichromate. To 
test the hypothesis that this effect was exerted by inhibition 
and/or scavenging of reactive oxygen species (ROS), the 
effect of BHT on the chromosomal damage induced by a 
high dose-rate gamma rays (HDR 192Ir). Experiments were 
carried out by irradiating G, CHO cells with nominal 
doses of 1, 2 or 3 Gy. BHT (doses of 1.0, 2.5 or 5.0 p-g/ml) 
was added to the culture immediately before or immedi­
ately after irradiation. Cells were then incubated in the 
presence of BHT for 13 h until harvesting and fixation. 
Results obtained showed that BHT did not decrease 
the chromosomal damage induced by radiation in any cons­
istent fashion. On the contrary, in cells post-treated with 
5.0 p,g/ml of BHT the yield of chromosomal aberrations 
increased in several experimental points. These results 
with ionizing radiation suggest that the previous observed 
protective effects of BHT on the chromosomal damage 
induced by chemical genotoxicants may not be mediated 
solely through the scavenging or inactivating reactive 
oxidative species. The decrease of the yield of chromosomal 
damage induced by BLM could be due to the union of BHT 
with a metallic ion, in this case Fe (II), required for the 
activation of BLM. In the same way, the protective effect of 
BHT on the chromosomal damage induced by cadmium 
chloride and potassium dichromate could be due to the 
decrease of the effective dose of both salts in the cell 
through the chelation of the cations by BHT.
Introduction
Butylated hydroxytoluene (BHT; 3,4-di-tert-butyl-4- 
hydroxytoluene; CAS number 128-37-0) is an effective 
synthetic antioxidant widely used in processed foods especially 
in oil and oil-based foods, where it has had a great economic 
impact. The biological effects of BHT have been evaluated in 
different in vivo and in vitro assays. Although most published 
data indicate that BHT and the related compotmd butylated 
hydroxyanisole (BHA) have beneficial effects there are some 
indications that their effects can be detrimental. For instance, 
BHT produces a marked delay in the development of the 
advanced stages of cataract formation (1). The compotmd 
decreases the chromosome aberrations induced in mammalian 
cells by bleomycin (BLM) (2), cadmium chloride and 
pottasium dichromate (3,4). BHT can either enhance or inhibit 
mutagenic potency, depending on the tested substance (5). In 
the Ames test, BHT is antimutagenic towards benzo(a)pyrene 
but it increases the number of Salmonella revertants induced by 
aflatoxin Bl (6,7). In Drosophila melanogaster, BHT exerts a 
radioprotective effect in sex-linked recessive lethal mutations 
induced by 2 krad of X-rays (8). Antioxidants also are able to 
modify neoplasic development, thereby enhancing or inhibi­
ting the development of lesions, depending on the target organ 
and the animal model (9-15).
Several studies indicate that BHT inhibits photocarcinogen- 
esis in animal models (16-18). Moreover, it inhibits aflatoxin 
Bl hepatocarcinogenesis in male Fisher 344 rats (19), In 
addition, BHT exerts protective effects against BLM-induced 
lung fibrosis and the development of associated hyperplastic 
lesions in hamsters (20).
On the other hand, BHT has been utilized in experimental 
studies to induce pulmonary inflamation (21), renal and hepatic 
damage (22). A metabolic derivative of BHT, BHT-quinone 
methide, interferes with glutathione-S-transferase Pl-1 regula­
tion of stress kinases, decresing cellular protection from 
electrophiles and oxidants (23). Faine and co-workers (24) 
reported that BHT induced toxic effects on serum lipids in 
Wistar rats through increased triacylglycerols, VLDL and 
LDL-cholesterol concentrations, but interestingly, the antiox­
idant enzymes were elevated, indicating that BHT constituted a 
long-term stressor agent.
Several possible mechanisms may account for the 
decrease of chromosomal aberrations produced by BHT in 
genotoxicant-treated cells. The first is that BHT acts as a true 
antioxidant, either preventing the formation of reactive oxigen 
species (ROS) or scavenging them. The second is that, BHT 
interferes competitively with BLM chelating Fe (II) and thus 
inhibiting the formation of ‘activated BLM’, a chelated 
complex formed after addition of oxigen to Fe (II) BLM 
(25). In the same way, chelation of cadmium and chromium 
cations by BHT could be the cause of the decrease of 
chromosome aberrations observed after combined treatments 
with cadmium and chromium salts and BHT (4).
In order to evaluate these possible mechanisms the effects of 
BHT on the yield of chromosome aberrations induced by a 
high-dose-rate (HDR; 192Ir) of irradiation in Chinese hamster 
ovary (CHO) cells, was studied. Gamma radiation causes DNA 
damage and chromosome aberrations both directly and 
indirectly. The indirect mechanism involves the generation of 
DNA-damaging radicals by water radiolysis without the 
intermediation of any metallic cations. If the protective effect 
of BHT is exerted mainly through its ability to prevent the 
formation or the scavenging of free radicals, a decrease of the 
yield of chromosomal aberrations induced by radiation should 
be expected.
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Materials and methods
CHO cell line was originally obtained from the American Type Culture 
Collection (ATCC, Rockville, MD). Mycoplasma-free cells were grown in 
Ham’s F10 medium (Gibco, Invitrogen, Argentina) supplemented with 10% 
heat-inactivated fetal calf serum (FCS), 50 IU/ml of penicillin and 50 pg/ml 
of streptomycin sulfate. The cells were cultured in T-25 plastic cell culture 
flasks, with 10 ml of culture medium at 37°C in a humidified atmosphere with 
5% CO2 in air. The duration of the cell cycle is checked periodically using the 
BrdU-Giemsa method (26) and varies between 12 and 15 h.
BHT (Sigma, St Louis, MO) was diluted in dimethylsulfoxide 
(DMSO; Sigma) before treatment and used at final concentration of 1.0, 
2.5 and 5.0 Jig/ml. The dilutions were made in order to add 0.1 ml of the 
solution to each culture to obtain the desired BHT concentration. DMSO 
final concentration was 1%.
The experiments were performed in order to analyse the effects of BHT on 
radiation-induced chromosomal aberrations were determined in the first 
metaphase after treatment. Chromosomal aberrations were classified following 
the criteria recommended by Archer and co-workers (27) and World Health 
Organization (28).
In all the experiments, quiescent CHO cells were dislodged with trypsin, 
subcultured into flasks containing fresh medium and irradiated after 2 h 
(Gi phase of the cell cycle). The cells were irradiated with nominal doses of 1, 2 
and 3 Gy of gamma rays at a HDR using Microselectron Nucleotron® equipped 
with a small source of 192Ir. The device was controlled by Indy® software run 
on a Silicon Graphics® computer.
For each radiation treatment T-25 culture flasks were placed on an acrylic 
plate containing six parallel needles separated by 10 mm. To obtain the 
programmed isodose curve the cell monolayers were placed at 7 mm over the 
needles. In the first experiment, the cells were irradiated and subsequently 
treated with 1.0, 2.5 and 5.0 Jig/ml of BHT until the cells were harvested and 
fixed 13 h later. In the second experiment, the cells were irradiated in the
presence of the different doses of BHT incubated for 13 h in medium containing 
BHT, and then harvested and fixed. Colchicine (0.1 Jlg/ml final concentration) 
was added to all the cultures for the last 2 h of the incubation period. The cells 
were harvested and fixed and slides prepared and air-dried according to routine 
protocols (29,30).
The frequencies of chromosomal aberrations were determined in the first 
metaphase after treatment. Each experiment was repeated three times. A total at 
300 metaphases per treatment (100 per repetition) were scored. Statistical 
analysis was performed using the %2 homogenicity test comparing each 
treatment with its corresponding control.
Results
Tables I, II and III summarize the results of the first experiment 
in which CHO cells were irradiated and subsequently treated 
with BHT. As expected (26), treatment with BHT alone 
induced a significant increase in the frequency of chromatid 
and isochromatid breaks (P < 0.001) in relation to the DMSO 
control. Similarly, treatment with 1, 2 and 3 Gy of radiation 
significantly increased the frequency of abnormal metaphases 
(P < 0.001) in relation to control. In combined treatments with 
radiation and 1.0 and 2.5 pg/ml BHT, the frequencies of 
abnormal metaphases were similar than those induced by 
radiation alone. The 5.0 pg/ml BHT treatment, however, 
increased the frequency of abnormal metaphases compared 
with irradiation alone (P < 0.01). With regard to the different 
types of aberrations, post-treatment with 1.0 pg/ml BHT 
increased the frequency of isochromatid breaks induced by
Table I. Frequencies of structural chromosome aberrations in CHO cells treated with 1, 2 and 3 Gy gamma radiation during Gi phase and then treated with 
1.0 pg/ml BHT
Treatment Abnormal 
metaphases (%Ÿ
Chromosomal aberrations per 100 cells Mitotic 
index %
AL B" B' RB' Frag DIC RING
— 0.3 0.3 (0.05) 0.3 (0.05) — — — — — 6.1
DMSO 1.6 1.3 (0.11) 1.3 (0.11) 0.3 (0.05) — — — — 6.0
BHT 9.0 0.6 (0.08) 3.6 (0.18) 5.0 (0.22) — 1.7 (0.12) 0.3 (0.05) 0.3 (0.05) 6.0
1 19.0 — 7.6 (0.26) 7.0 (0.25) 1.3 (0.11) — 5.3 (0.22) 1.3 (0.11) 5.9
2 23.3 0.3 (0.05) 6.0 (0.24) 3.3 (0.17) 1.3 (0.11) 4.7 (0.20) 12.3 (0.33) 2.3 (0.14) 5.6
3 27.8 — 4.9 (0.22) 4.9 (0.22) 1.5 (0.12) 9.2 (0.30) 16.0 (0.36) 3.0 (0.17) 5.8
1 + BHT 21.0 — 7.6 (0.26) 6.3 (0.24) — — 7.6 (0.26) 2.0 (0.14) 5.8
2 + BHT 27.3 0.3 (0.05) 7.3 (0.26) 8.0 (0.27) 2.0 (0.14) — 14.0 (0.35) 4.0 (0.19) 6.0
3 + BHT 29.0 — 5.0 (0.22) 4.5 (0.21) — 5.0 (0.22) 18.5 (0.39) 5.5 (0.22) 5.9
For each experimental point 300 cells were scored. Standard error of mean is shown in the parentheses. AL, achromatic lesions; B", chromatid breaks;
Bz, isochromatid breaks; RBZ, chromatid exchanges; Frag, chromosome fragments; DIC, dicentric chromosomes; RING, chromosome rings. 
aAbnormal metaphases are metaphases with at least one chromosomal aberration. Metaphases exhibiting only achromatic lesions were not scored as abnormal.
Table IL Frequencies of structural chromosome aberrations in CHO cells treated with 1, 2 and 3 Gy gamma radiation during Gi phase and then treated with 
2.5 pg/ml BHT
Treatment Abnormal 
metaphases (%)a
Chromosomal aberrations per 100 cells Mitotic 
index (%)
AL B" B' RB' Frag DIC RING
— 0.3 0.6 (0.08) 0.3 (0.05) — — — — — 6.0
DMSO 1.6 2.0 (0.14) 1.0 (0.09) 0.6 (0.08) — 0.3 (0.05) — — 6.2
BHT 8.3 0.3 (0.05) 5.6 (0.23) 5.0 (0.22) — 0.3 (0.05) — — 5.0
1 20.0 — 3.0 (0.17) 5.3 (0.22) 0.6 (0.08) — 9.3 (0.29) 2.6 (0.16) 6.0
2 26.3 0.6 (0.08) 4.3 (0.19) 4.3 (0.19) 2.6 (0.16) 5.8 (0.23) 17.6 (0.38) 2.6 (0.16) 6.2
3 37.0 — 7.6 (0.26) 2.7 (0.16) 1.5 (0.12) 19.0 (0.40) 24.4 (0.43) 5.7 (0.23) 5.8
1 + BHT 20.3 — 4.0 (0.19) 7.6 (0.26) 1.0 (0.09) 1.7 (0.12) 8.6 (0.28) 1.0 (0.09) 5.5
2 + BHT 29.3 0.3 (0.05) 3.0 (0.17) 5.0 (0.22) 2.3 (0.15) 4.0 (0.19) 14.0 (0.35) 5.6 (0.23) 5.0
3 + BHT 39.0 1.8 (0.13) 5.3 (0.22) 6.0 (0.24) 1.3 (0.11) 9.4 (0.30) 20.6 (0.40) 10.0 (0.30) 5.4
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Table III. Frequencies of structural chromosome aberrations in CHO cells treated with 1, 2 and 3 Gy gamma radiation during Gx phase and then treated 
with 5.0 Jlg/ml BHT
Treatment Abnormal 
metaphases (%)a
Chromosomal aberrations per 100 cells Mitotic 
index (%)
AL B" B' RB' Frag DIC RING
— 0.6 0.3 (0.05) 0.6 (0.08) — — — — — 5.9
DMSO 2.0 2.0 (0.14) 1.3 (0.11) 0.6 (0.08) — — — — 5.8
BHT 7.0 0.3 (0.05) 5.6 (0.22) 2.0 (0.14) — — — — 4.1
1 22.6 — 7.3 (0.26) 3.3 (0.17) 0.3 (0.05) 1.7 (0.12) 7.6 (0.26) 1.0 (0.09) 6.0
2 28.0 0.3 (0.05) 8.6 (0.28) 2.3 (0.15) 1.3 (0.11) 7.4 (0.26) 8.3 (0.27) 3.3 (0.17) 6.0
3 32.6 — 5.3 (0.22) 3.0 (0.17) 1.6 (0.12) 14.7 (0.35) 14.3 (0.35) 4.3 (0.20) 4.2
1 + BHT 25.3 — 7.3 (0.26) 6.6 (0.25) 0.3 (0.05) 4.1 (0.19) 10.3 (0.30) 0.6 (0.08) 4.0
2 + BHT 34.6 — 10.3 (0.30) 3.3 (0.17) 0.6 (0.08) 1.0 (0.09) 16.0 (0.36) 4.0 (0.19) 5.0
3 + BHT 38.0 0.3 (0.05) 10.0 (0.30) 3.6 (0.18) 1.3 (0.11) 11.4 (0.32) 11.6 (0.32) 8.3 (0.27) 3.9
For each experimental point 300 cells were scored. Standard error of mean is shown in the parentheses. AL, achromatic lesions; B", chromatid breaks;
Bz, isochromatid breaks; RBZ, chromatid exchanges; Frag, chromosome fragments; DIC, dicentric chromosomes; RING, chromosome rings. 
aAbnormal metaphases are metaphases with at least one chromosomal aberration. Metaphases exhibiting only achromatic lesions were not scored as abnormal.
Table IV. Frequencies of structural chromosome aberrations in CHO cells treated with 1, 2 and 3 Gy gamma radiation in the presence of 1.0 Lig/ml during 
Gt phase
Treatment Abnormal 
metaphases (%)a
Chromosomal aberrations per 100 cells Mitotic 
index (%)
AL B" B' RB' Frag DIC RING
— 1.0 0.3 (0.05) 1.0 (0.09) — — — — — 6.0
DMSO 1.3 — 1.0 (0.09) 0.3 (0.05) — — — — 6.2
BHT 4.3 0.3 (0.05) 2.3 (0.15) 2.3 (0.15) — — — — 5.9
1 21.0 — 4.6 (0.21) 6.6 (0.25) 2.0 (0.14) 4.0 (0.19) 8.0 (0.27) — 5.8
2 23.3 0.3 (0.05) 7.3 (0.26) 3.0 (0.17) 1.6 (0.12) 2.4 (0.15) 13.3 (0.34) 2.3 (0.15) 6.0
3 31.3 0.3 (0.05) 3.3 (0.18) 5.3 (0.22) 1.6 (0.12) 7.7 (0.26) 18.3 (0.38) 5.3 (0.22) 6.1
1 + BHT 24.0 1.0 (0.09) 6.6 (0.25) 4.6 (0.21) 0.6 (0.08) 4.3 (0.20) 9.0 (0.28) 2.0 (0.14) 5.9
2 + BHT 24.6 — 3.6 (0.19) 5.6 (0.23) 1.3 (0.11) 2.0 (0.14) 12.0 (0.32) 3.3 (0.18) 5.6
3 + BHT 34.3 — 4.0 (0.19) 6.0 (0.24) 2.0 (0.14) 12.7 (0.33) 20.6 (0.40) 5.3 (0.22) 5.8
For each experimental point 300 cells were scored. Standard error of mean is shown in the parentheses. AL, achromatic lesions; B", chromatid breaks;
Bz, isochromatid breaks; RBZ, chromatid exchanges; Frag, chromosome fragments; DIC, dicentric chromosomes; RING, chromosome rings. 
aAbnormal metaphases are metaphases with at least one chromosomal aberration. Metaphases exhibiting only achromatic lesions were not scored as abnormal.
2 Gy (P < 0.001), the frequency of chromosome fragments 
induced by 1 Gy (P < 0.05) and the frequency of chromosome 
rings induced by 3 Gy (P < 0.01) (Table I). 2.5 pg/ml BHT 
increased the frequency of isochromatid breaks in cells 
irradiated with 3 Gy (P < 0.001) and the frequency 
chromosome rings in the cells irradiated with 2 and 3 Gy 
(P < 0.01) (Table II). Post-treatment with 5.0 pg/ml of BHT 
resulted in significant increases in the frequencies of chromatid 
breaks (P < 0.001), isochromatid breaks (P < 0.01), 
chromosome fragments (P < 0.01) and dicentric chromosomes 
(P < 0.001) in cells irradiated with 3, 1, 1 and 2 Gy, 
respectively (Table III).
Tables IV, V and VI show the results of the second 
experiment in which cells were irradiated in the presence of 
BHT and incubated with the compound until fixation. With this 
protocol, there were no differences in the frequency of 
abnormal metaphases between treatments conducted with 
radiation alone and treatments with HDR-192Ir plus the three 
concentrations of BHT. Cells irradiated with 2 Gy in the 
presence of 1.0 yg/ml of BHT showed a decrease in the 
frequency of chromatid breaks (P < 0.025). On the other hand, 
irradiation with 2, 3 and 1 Gy increased the frequencies of 
isochromatid breaks (P < 0.01), chromosome fragments 
(P < 0.025) and chromosome rings (P < 0.01), respectively 
(Table IV). With the dose of 2.5 pg/ml BHT an increase of
the frequency of chromatid breaks induced by 1 Gy irradiation 
(P < 0.05) and a decrease of the frequency of chromosome 
fragments in cells irradiated with 3 Gy (P < 0.05) was found. 
Finally, cells irradiated with 1 Gy in the presence of 5.0 pg/ml 
BHT exhibited a decrease in the frequency of chromatid breaks 
(P < 0.025) and an increase in the frequency of chromosome 
rings (P < 0.01). The dose of 5.0 pg/ml BHT also increased 
in the frequency of isochromatid breaks induced by 2 and 3 Gy 
(P < 0.05 and < 0.025, respectively).
The cytotoxicity of different treatment was established by 
scoring the mitotic index, which decreased with increasing 
doses of BHT.
Figure 1 shows that there are not differences between cells 
irradiated and post-treated with BHT (B) and in cells irradiated 
in the presence of the compound (C). In both cases, the bars 
corresponding to the combined treatments are similar to those 
corresponding to the cells treated only with radiation alone
Discussion
The results obtained, under the experimental conditions of this 
study, show that BHT does not protect cells from the 
chromosomal damage induced by ionizing radiation. A 
decrease in the frequency of some chromosome aberrations 
was detected in few experimental points (chromatid breaks
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Table V. Frequencies of structural chromosome aberrations in CHO cells treated with 1, 2 and 3 Gy gamma radiation in the presence of 2.5 ug/ml during 
Gt phase
Treatment Abnormal 
metaphases (%)a
Chromosomal aberrations per 100 cells Mitotic 
index (%)
AL B" B' RB' Frag DIC RING
— 1.3 0.3 (0.05) 1.3 (0.11) — — — — — 5.8
DMSO 2.0 — 1.3 (0.11) 0.6 (0.08) — — — — 5.6
BHT 6.3 0.3 (0.05) 3.3 (0.18) 5.0 (0.22) — — — — 4.6
1 20.6 — 4.3 (0.20) 6.3 (0.24) 1.0 (0.09) 3.6 (0.18) 8.0 (0.27) — 6.2
2 23.6 0.3 (0.05) 8.0 (0.27) 3.0 (0.17) 1.6 (0.12) 3.1 (0.17) 12.6 (0.33) 2.6 (0.16) 6.0
3 33.3 0.3 (0.05) 4.3 (0.20) 5.0 (0.22) 1.3 (0.11) 11.1 (0.32) 18.6 (0.39) 5.3 (0.22) 5.8
1 + BHT 18.6 — 7.0 (0.25) 4.0 (0.19) 1.6 (0.12) 4.7 (0.21) 8.0 (0.27) 1.3 (0.11) 4.7
2 + BHT 24.0 0.6 (0.08) 6.6 (0.25) 3.0 (0.17) 2.3 (0.15) 6.3 (0.25) 9.0 (0.28) 3.0 (0.17) 4.9
3 + BHT 34.3 — 5.3 (0.22) 4.0 (0.19) 3.3 (0.18) 5.0 (0.22) 16.3 (0.37) 6.0 (0.24) 4.5
For each experimental point 300 cells were scored. Standard error of mean is shown in the parentheses. AL, achromatic lesions; B", chromatid breaks;
B', isochromatid breaks; RB', chromatid exchanges; Frag, chromosome fragments; DIC, dicentric chromosomes; RING, chromosome rings.
“Abnormal metaphases are metaphases with at least one chromosomal aberration. Metaphases exhibiting only achromatic lesions were not scored as abnormal.
Table VI. Frequencies of structural chromosome aberrations in CHO cells treated with 1, 2 and 3 Gy gamma radiation in the presence of 5.0 ug/ml during 
Gt phase
Treatment Abnormal 
metaphases (%)a
Chromosomal aberrations per 100 cells Mitotic 
index (%)
AL B" B' RB' Frag DIC RING
— 1.0 1.3 (0.11) 0.6 (0.08) 0.3 (0.05) — — — — 6.0
DMSO 1.6 1.3 (0.11) 1.6 (0.12) — — — — — 6.2
BHT 7.3 0.6 (0.08) 5.6 (0.23) 4.0 (0.19) 0.3 (0.05) 0.3 (0.05) — — 3.9
1 18.0 — 6.3 (0.24) 3.6 (0.18) 2.0 (0.14) — 8.6 (0.28) 0.3 (0.05) 6.4
2 23.6 0.3 (0.05) 10.0 (0.30) 2.6 (0.16) 0.6 (0.08) 4.3 (0.20) 11.3 (0.32) 2.0 (0.14) 5.6
3 29.3 0.3 (0.05) 5.6 (0.23) 3.0 (0.17) 1.6 (0.12) 3.3 (0.18) 18.0 (0.38) 3.3 (0.18) 5.7
1 + BHT 18.6 0.6 (0.08) 3.3 (0.18) 3.3 (0.18) 1.6 (0.12) 1.7 (0.12) 5.6 (0.23) 2.3 (0.15) 4.3
2 + BHT 25.0 — 7.6 (0.26) 4.6 (0.21) 1.3 (0.11) 5.0 (0.22) 11.3 (0.32) 2.3 (0.15) 4.0
3 + BHT 28.3 — 6.6 (0.25) 5.3 (0.22) 1.6 (0.12) 8.7 (0.28) 13.3 (0.34) 4.0 (0.19) 4.1
For each experimental point 300 cells were scored. Standard error of mean is shown in the parentheses. AL, achromatic lesions; B", chromatid breaks;
B', isochromatid breaks; RB', chromatid exchanges; Frag, chromosome fragments; DIC, dicentric chromosomes; RING, chromosome rings.
“Abnormal metaphases are metaphases with at least one chromosomal aberration. Metaphases exhibiting only achromatic lesions were not scored as abnormal.
with 2 Gy plus 1.0 idg/ml of BHT and 1 Gy plus 5.0 pg/tnl of 
BHT; chromosome fragments with 3 Gy plus 2.5 yg/ml of 
BHT). However, most treatments involving combinations 
of BHT and irradiation resulted in chromosome aberrations 
frequencies that were not different from those produced by 
irradiation alone. In addition BHT co-treatment had less of an 
effect on the overall frequency of abnormal metaphases in 
irradiated cells. Except for the treatment with 5.0 ilg/inl of 
BHT following irradiation, where a significant increase was 
observed. BHT had no significant effects on the overall 
radiation-induced aberration frequency. Previous studies 
indicated that BHT protected cells against the chromosomal 
damage induced by BLM, cadmium chloride and potassium 
dichromate (2,4).
The results obtained in this study support the proposal that 
BHT may decrease chromosome aberrations induced by these 
chemicals by a mechanism not involving the scavenging or 
inactivation of ROS. BHT could decrease the clastogenic 
effects of BLM by the union of BHT with a metallic ion, in this 
case Fe (II), which is required for the activation of BLM. In this 
way, the balance between the active and inactive forms of 
BLM could be altered, reducing the clastogenic properties of 
the drug (25). In the same way, the protective effect of BHT on 
the chromosomal damage induced by cadmium chloride and 
potassium dichromate could be due to the decreases in the 
effective doses of both salts in the cell through chelation of the 
cations by BHT (4). In addition, Gulcin and co-workers (31) 
demonstrated the metal chelating and hydrogen peroxide 
scavenging activity of BHT who exhibited a 72% inhibition 
of the formation of the Fe (Il)-ferrozine complex and 
scavenged 23% of hydrogen peroxide.
The differences between the effect of BHT on the 
chromosomal damage induced by BLM and ionizing radiation 
are illustrated in Figure 1. The figure shows the frequency of 
cells with chromosome and chromatid-type aberrations as 
well as cells with both types of aberrations. All three freq­
uencies were increased in cells treated with BLM or radiation 
during Gp Figure 1A shows the effect of BHT on the 
chromosomal damage induced by BLM. BLM decreased the 
frequency of cells with chromosome-type aberrations, but it 
had no effect on cells with chromatid-type aberrations or with 
both types of aberrations (2). Figure IB and C illustrates 
the effect of BHT in cells irradiated and post-treated with the 
antioxidant (B) and in cells irradiated in the presence of 
the compound (C). In all cases, the bars corresponding to the 
combined treatments are similar to those corresponding to the 
cells treated only with radiation alone. From the results 
obtained it can be inferred that BHT could interact with trace 
elements modifying cell homeostasis and metabolism. Thus, 
BHT might interact in cells, tissues and organisms exposed to 
genotoxic and non-genotoxic agents (other phenolic com­
pounds) modifying their action. For these reasons we believe
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A
Cont DMSO BHT 1 Gy 2 Gy J Gy 1 Gy 2 Gy 3 Gy
BHT BHT BHT
Cont DMSO BHT 1 Gy 2 Gy 3 Gy 1 Gy 2 Gy 3 Gy
BHT BHT BHT
Fig. 1. Frequencies of cells with different types of aberrations treated (A) with 
BLM (doses of 0.1, 0.5 and 1.0 g/ml for BLM1, BLM2 and BLM3, 
respectively) plus 1.0 g/ml BHT (B) HDR 192Ir and then treatment with 
1.0 g/ml BHT (C) HDR 192Ir plus 1.0 g/ml BHT. Black bars, frequency of 
chromosome-type aberrations. White bars, frequency of chromatid-type 
aberrations. Grey bars, frequency of cells with aberrations of both types.
c
that more extensive assessment of food additives in current use 
is warranted.
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